What You Should Know
The Launch: Amazon One Medical has rolled out a nationwide GLP-1 management program that explicitly integrates obesity treatment with comprehensive primary care.The Clinical Differentiator: Unlike direct-to-consumer "pill mills" that simply dispense weight loss drugs, Amazon is treating obesity as a chronic condition. Because GLP-1s can rapidly alter blood pressure and A1C levels, One Medical clinicians proactively adjust a patient's existing hypertension or diabetes
Read More
GLP-1
Walmart Expands Better Care Services Platform with GLP-1 Weight Management Offerings
What You Should Know
The Expansion: Walmart is heavily expanding its digital health platform, Better Care Services, to include comprehensive weight management support for customers exploring or currently taking GLP-1 therapies.The Digital Health Bundle: The retail giant is acting as a centralized hub, partnering with third-party digital health companies including Aaptiv (fitness), Berry Street (registered dietitians), Curai Health (AI-supported coaching), MyCare by Twin Health (metabolic
Read More
Wegovy HD Now Available on GoodRx for $399 Per Month Self-Pay
What You Should Know
The Launch: GoodRx has announced it is now offering Wegovy HD—Novo Nordisk’s newly introduced, higher-dose (7.2 mg) semaglutide injection.The Price Point: In a major move for the direct-to-consumer market, the medication is available to eligible self-pay patients at a transparent price of $399 per month. Pricing scales predictably to $798 for a two-month supply and $1,197 for a three-month supply.The Clinical Strategy: Wegovy HD serves as an FDA-approved "step-up" option
Read More
eMed Secures $200M Series A at $2B+ Valuation to Scale AI-Powered GLP-1 Employer Platform
What You Should Know
The Mega-Round: Miami-based eMed has raised a $200M Series A funding round, catapulting the company to a valuation of over $2 billion. The round was led by AON Consulting, Inc.The Power Roster: The executive and investor lineup is uniquely high-profile. Former X CEO Linda Yaccarino is now at the helm as eMed's CEO. NFL legend Tom Brady serves as both an investor and the Founding Chief Wellness Officer. The cap table also includes tech and finance heavyweights like Joe
Read More
Weight Watchers Releases GLP-1 Results Report Demonstrating 61% Greater Weight Loss
What You Should Know:
The Strategic Pivot Validated: Weight Watchers (WW) has released GLP-1 Results Report validating its integrated weight health platform, which combines medical therapy with behavioral support.The Core Data: Members who actively paired weight loss medication with the WW GLP-1 Success Program achieved 61.3% greater average weight loss in their first month compared to those who did not engage in behavioral support.Long-Term Efficacy: WW Med+ members prescribed GLP-1s reached
Read More
Walgreens Launches $49 Pay-Per-Visit Weight Management, Expanding Virtual Healthcare Platform
What You Should Know
The Launch: Walgreens has officially launched Walgreens Weight Management, expanding its Virtual Healthcare platform to offer personalized, clinician-guided weight loss support for eligible adults ages 18-64.The Clinical Pathway: Eligible patients complete an online video visit with a licensed doctor or nurse practitioner who evaluates their medical history and goals. Providers can then prescribe FDA-approved GLP-1 medications (like Wegovy) for weight loss.The Pricing
Read More
GLP-1: Amazon Pharmacy Adds Zepbound KwikPen to Its Same-Day Delivery for $299
What You Should Know
The Launch: Amazon Pharmacy has officially expanded its weight management portfolio by adding Eli Lilly's Zepbound® KwikPen® to its digital shelves.The Hardware: Unlike traditional single-use GLP-1 auto-injectors, the KwikPen is a multi-dose device designed to deliver a full month of medication in a single pen, reducing medical waste and simplifying the patient experience.The Disruption: Bypassing the murky world of Pharmacy Benefit Managers (PBMs), Amazon is offering
Read More
Walgreens Launches Virtual Weight Management Platform for Self-Pay GLP-1 Patients
What You Should Know
The Launch: Walgreens has expanded its virtual healthcare platform to include Walgreens Weight Management, a digital clinic connecting eligible adults (18-64) with doctors or nurse practitioners to obtain FDA-approved weight loss medications.The Pricing Model: In a direct shot at subscription-heavy telehealth competitors, Walgreens is charging a flat $49 per visit with zero monthly subscription fees.The Target Audience: The service is explicitly designed for the
Read More
How Employers Can Save $550/Month on GLP-1s: Introducing Vida Self-Pay
What You Should Know
- Vida Health has partnered with RxSaveCard to launch Vida Self-Pay, a first-of-its-kind platform that bypasses traditional PBM markups for anti-obesity medications (AOMs).
- By combining virtual, whole-person clinical care with transparent "cash-price" subsidies, the partnership enables employers to save up to $550 per member per month while expanding access to GLP-1s and other AOMs.
Bypassing the PBM "Walled Garden"
The Vida Self-Pay model functions as a
Read More
Noom Pivots to Longevity: New Program Combines Microdose GLP-1s with At-Home Biomarker Testing
What You Should Know:
- Noom has launched Proactive Health Microdose GLP-1Rx, a first-of-its-kind preventive health program designed to intervene before chronic disease takes root.
- Available to individuals with a BMI of 21 or higher, the offering combines personalized microdoses of GLP-1 medication with comprehensive at-home biomarker testing and Noom’s digital behavior modification platform.
- Priced at $149 per month, the program aims to shift the healthcare paradigm
Read More
